| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 739.09M | 784.65M | 833.98M | 944.30M | 927.81M |
| Gross Profit | 201.86M | 284.13M | 355.56M | 455.05M | 446.40M |
| EBITDA | 498.05M | 572.69M | 697.95M | 770.61M | 745.92M |
| Net Income | 141.78M | 205.22M | 237.65M | 231.61M | 263.38M |
Balance Sheet | |||||
| Total Assets | 6.94B | 6.97B | 7.09B | 7.13B | 7.30B |
| Cash, Cash Equivalents and Short-Term Investments | 2.73B | 2.45B | 2.15B | 1.75B | 1.37B |
| Total Debt | 82.64M | 111.32M | 146.94M | 166.79M | 182.91M |
| Total Liabilities | 779.34M | 877.44M | 1.00B | 1.06B | 1.16B |
| Stockholders Equity | 6.16B | 6.09B | 6.08B | 6.07B | 6.13B |
Cash Flow | |||||
| Free Cash Flow | 392.31M | 416.35M | 549.73M | 658.64M | 598.80M |
| Operating Cash Flow | 439.33M | 455.91M | 566.91M | 661.57M | 626.94M |
| Investing Cash Flow | -391.37M | 40.59M | -628.12M | -585.52M | -321.52M |
| Financing Cash Flow | -111.14M | -210.85M | -232.25M | -272.03M | -243.32M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$3.45B | 18.21 | 2.99% | 4.25% | -5.81% | -31.09% | |
70 Outperform | HK$10.40B | 9.94 | 8.45% | 7.46% | -0.06% | 1.10% | |
70 Outperform | HK$605.44B | 13.34 | 7.19% | 5.40% | 1.29% | -3.41% | |
69 Neutral | HK$29.85B | 1.65 | 7.60% | 5.24% | 0.06% | 78.59% | |
67 Neutral | HK$95.69B | 16.50 | 14.46% | 2.86% | 5.18% | 4.25% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
46 Neutral | HK$47.15B | 34.49 | -2.39% | 1.68% | 7.18% | 15.72% |